HNN3.0
Register
Register
Register

Project cooperationUpdated on 14 January 2026

Design and manufacturing antidote autoinjector

Mec president at Professor of biomedical Engineering , MEC

cairo, Egypt

About

Autoinjector devices (AIDs) are useful for the rapid administration of drugs and antidotes and they can also be used by those who have not been medically trained.Autoinjector devices (AIDs) are useful for the rapid administration of drugs and antidotes and they can also be used by those who have not been medically trained.

The Objectives : to a novel Design and manufacturing of an autoinjector device for antidote administration ; where The drug cartridges can be replaced after the shelf-life has been exceeded and the AID itself has the advantage of being reusable and  interchangeable.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Partner seeks Consortium/Coordinator

Organisation

Similar opportunities

  • Project cooperation

    PET imaging-guided new drug development

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Xiang-Guo Li

    Professor at University of Turku

    Turku, Finland

  • Project cooperation

    MaltaKnee

    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Pierre Schembri-Wismayer MD PhD

    Professor of Anatomy, PI at the Centre for Molecular Medicine and Biobanking at University of Malta

    Msida, Malta

  • Project cooperation

    Préclinically confirmed slow release capsules for cancer

    Stefan MC MURTRY Ph.D.

    CNRS senior scientist #Slow release capsules for cancer at Medicaps CNRS

    Nancy, France